S100A8/A9-RAGE pathway and chronic airway inflammation in smoke-induced lung carcinogenesis

[1]  N. Leighl,et al.  Tobacco exposure and immunotherapy response in PD-L1 positive lung cancer patients. , 2020, Lung cancer.

[2]  M. Sakaguchi,et al.  S100 Soil Sensor Receptors and Molecular Targeting Therapy Against Them in Cancer Metastasis , 2020, Translational oncology.

[3]  W. Greenhalf,et al.  S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes , 2018, BMC Cancer.

[4]  I. Rahman,et al.  Inhibition of RAGE Attenuates Cigarette Smoke-Induced Lung Epithelial Cell Damage via RAGE-Mediated Nrf2/DAMP Signaling , 2018, Front. Pharmacol..

[5]  P. Reynolds,et al.  Cigarette smoke extract induces oral squamous cell carcinoma cell invasion in a receptor for advanced glycation end‐products‐dependent manner , 2018, European journal of oral sciences.

[6]  Fuqiang Wen,et al.  Knockout of RAGE ameliorates mainstream cigarette smoke‐induced airway inflammation in mice , 2017, International immunopharmacology.

[7]  P. Reynolds,et al.  Cigarette smoke extract (CSE) induces RAGE-mediated inflammation in the Ca9-22 gingival carcinoma epithelial cell line. , 2017, Archives of oral biology.

[8]  Bin Wang,et al.  HMGB1 translocation and release mediate cigarette smoke–induced pulmonary inflammation in mice through a TLR4/MyD88-dependent signaling pathway , 2017, Molecular biology of the cell.

[9]  R. Muschel,et al.  Tumor-infiltrating monocytes/macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cells , 2016, Oncogene.

[10]  S. De Flora,et al.  Pharmacological Modulation of Lung Carcinogenesis in Smokers: Preclinical and Clinical Evidence. , 2016, Trends in pharmacological sciences.

[11]  Fuqiang Wen,et al.  RAGE‐ligands axis: A new ‘driving force’ for cigarette smoke‐induced airway inflammation in COPD? , 2015, Respirology.

[12]  M. Rebelatto,et al.  S100A9 Induced Inflammatory Responses Are Mediated by Distinct Damage Associated Molecular Patterns (DAMP) Receptors In Vitro and In Vivo , 2015, PloS one.

[13]  G. Srikrishna.  S100A8 and S100A9: New Insights into Their Roles in Malignancy , 2011, Journal of Innate Immunity.

[14]  Stephen Yau,et al.  The role of inflammation in the pathogenesis of lung cancer , 2011, Expert opinion on therapeutic targets.

[15]  E. Duhig,et al.  Common pathogenic mechanisms and pathways in the development of COPD and lung cancer , 2011, Expert opinion on therapeutic targets.

[16]  Ian M. Adcock,et al.  Chronic Obstructive Pulmonary Disease and Lung Cancer: New Molecular Insights , 2011, Respiration.

[17]  S. Ostrand-Rosenberg.  Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity , 2010, Cancer Immunology, Immunotherapy.

[18]  A. Coyle,et al.  HMGB1 and RAGE in inflammation and cancer. , 2010, Annual review of immunology.

[19]  E. Szabo,et al.  Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research. , 2009, Journal of the National Cancer Institute.

[20]  W. Nacken,et al.  Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein , 2008, The Journal of experimental medicine.

[21]  R. Ramasamy,et al.  Arguing for the motion: yes, RAGE is a receptor for advanced glycation endproducts. , 2007, Molecular nutrition & food research.

[22]  Ting Wang,et al.  A review of S100 protein family in lung cancer. , 2018, Clinica chimica acta; international journal of clinical chemistry.